Recent News

• 12.12.2025 - GRI Bio Announces Closing of $8.0 Million Public Offering
• 12.10.2025 - GRI Bio Announces Positive Topline Data from its Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”)
• 09.11.2025 - GRI Bio Reports 6-Week Interim Lung Function Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”)

Recent Filings

• 12.10.2025 - S-1/A General form for registration of securities under the Securities Act of 1933
• 12.10.2025 - 8-K Current report
• 12.10.2025 - EX-99.1 EX-99.1
• 12.08.2025 - S-1 General form for registration of securities under the Securities Act of 1933
• 12.08.2025 - 8-K Current report
• 12.08.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 12.02.2025 - 8-K Current report
• 11.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.14.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 09.22.2025 - 4 Statement of changes in beneficial ownership of securities